The European Health Data Space and biobanking in Europe: synergies, tensions and the future governance of data-driven health research
Open Access
- 10 September 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 17, 1932078
Abstract
The European Health Data Space (EHDS) represents the most ambitious attempt to date to create a common legal, technical and governance framework for the use of health data across the European Union. Its adoption creates a new infrastructure for both primary use, focusing on cross-border access to electronic health records for care, and secondary use, centred on research, innovation, public health, regulatory science and policymaking. In parallel, European biobanking has matured into a core research infrastructure supporting genomic medicine, biomarker discovery, rare disease research and precision public health. The convergence of EHDS-enabled electronic health records, BBMRI-ERIC-associated biobanks, and the 1+ Million Genomes initiative offers a plausible route towards federated, large-scale, molecularly informed health systems in Europe. This article critically examines that opportunities and challenges arising from this convergence. It argues that the EHDS and biobanking are complementary but not automatically interoperable. Biobanks provide depth: biospecimens, molecular assays, longitudinal cohorts and consented research infrastructures. The EHDS provides breadth: population-scale clinical trajectories, regulatory gateways, Health Data Access Bodies and Secure Processing Environments. The 1+ Million Genomes and Genomic Data Infrastructure initiatives provide a genomics-specific federated layer that may connect these ecosystems through standards such as GA4GH, Beacon, Phenopackets and FHIR-Genomics. However, substantial obstacles remain. These include uneven digital maturity across Member States, immature representation of biospecimen and omics metadata in clinical data models, unresolved interactions between EHDS opt-out mechanisms and biobank consent, fragmented national interpretations of the GDPR, sustainability constraints, environmental costs of petabyte-scale computing, and the risk that artificial intelligence trained on biased or incomplete datasets will reproduce health inequities. We argue that EHDS-biobank integration should not be regarded solely as a technical exercise. Rather, it represents a governance challenge involving trust, reciprocity, legal interpretation, standards development, infrastructure investment and public legitimacy. Without coordinated action, the EHDS may create a formally integrated yet substantively unequal data ecosystem. Conversely, with deliberate design and effective governance, it has the potential to provide Europe with a trustworthy, federated and clinically actionable research infrastructure.Keywords
Funding Information
- Università ta' Malta
This publication has 141 references indexed in Scilit:
- The Survivorship Passport for childhood cancer survivors: improvements and experience within several European PanCare projectsJournal of Cancer Survivorship, 2026
- Understanding the Barriers to Translating Artificial Intelligence into the Clinical LaboratoryEuropean Journal of Internal Medicine, 2026
- Intellectual property (IP) rights governance and related value mechanisms in Common European Data SpacesData in Brief, 2026
- Artificial Intelligence For 6P Medicine: Consolidating AI Needs of Predictive, Preventive, Personalized, Participatory, Precision, and Public Health TrajectoriesJournal of Medical Systems, 2026
- The European Health Data Space as a Case StudyEthics & Human Research, 2024
- Will the GDPR Restrain Health Data Access Bodies Under the European Health Data Space (EHDS)?Computer Law & Security Review, 2024
- Beacon v2 and Beacon networks: A “lingua franca” for federated data discovery in biomedical genomics, and beyondHuman Mutation, 2022
- The emerging landscape of health research based on biobanks linked to electronic health records: Existing resources, statistical challenges, and potential opportunitiesStatistics in Medicine, 2019
- Biobank governance: heterogeneous modes of ordering and democratizationJournal of Community Genetics, 2011
- Biobanking residual tissuesHuman Genetics, 2011